Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Next Deadline
10 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
July 25, 2025
Extension Available
Until July 25, 2024
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 27, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 27, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 9, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 9, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 16, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 16, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 25, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 30, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 30, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 10, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 17, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 17, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 17, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 21, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 20, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 20, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 21, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 21, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 21, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 7, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 4, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 3, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
042